128 related articles for article (PubMed ID: 21118194)
1. Immunosuppressive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are going.
Risitano AM
Br J Haematol; 2011 Jan; 152(2):127-40. PubMed ID: 21118194
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapies in the management of acquired immune-mediated marrow failures.
Risitano AM
Curr Opin Hematol; 2012 Jan; 19(1):3-13. PubMed ID: 22143074
[TBL] [Abstract][Full Text] [Related]
3. Novel immunosuppressive strategies for bone marrow failure syndromes: a focus on alemtuzumab.
Selleri C; Serio B; Risitano AM
Mini Rev Med Chem; 2011 Jun; 11(6):536-43. PubMed ID: 21561402
[TBL] [Abstract][Full Text] [Related]
4. New Trends in Nontransplant Therapy for Acquired Aplastic Anemia.
Ding S; Fu R
Curr Pharm Des; 2022; 28(21):1730-1737. PubMed ID: 35440301
[TBL] [Abstract][Full Text] [Related]
5. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
[TBL] [Abstract][Full Text] [Related]
6. Aplastic anemia: immunosuppressive therapy in 2010.
Risitano AM; Perna F
Pediatr Rep; 2011 Jun; 3 Suppl 2(Suppl 2):e7. PubMed ID: 22053283
[TBL] [Abstract][Full Text] [Related]
7. Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine.
Scheinberg P; Marte M; Nunez O; Young NS
Haematologica; 2010 Jul; 95(7):1075-80. PubMed ID: 20595102
[TBL] [Abstract][Full Text] [Related]
8. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
[TBL] [Abstract][Full Text] [Related]
9. Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia.
Zeng W; Nakao S; Takamatsu H; Yachie A; Takami A; Kondo Y; Sugimori N; Yamazaki H; Miura Y; Shiobara S; Matsuda T
Blood; 1999 May; 93(9):3008-16. PubMed ID: 10216097
[TBL] [Abstract][Full Text] [Related]
10. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
Chen C; Fang JP; Huang SL; Zhong FY
Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
[TBL] [Abstract][Full Text] [Related]
11. Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia.
Scheinberg P; Nunez O; Young NS
Br J Haematol; 2006 Jun; 133(6):622-7. PubMed ID: 16704436
[TBL] [Abstract][Full Text] [Related]
12. Severe aplastic anaemia--complete response to antilymphocyte globulin and cyclosporin.
Jones-Lecointe A; Murphy A; Charles W; Daisley H; Pitt-Miller P
West Indian Med J; 1999 Dec; 48(4):238-9. PubMed ID: 10639849
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study.
Kulagin A; Lisukov I; Ivanova M; Golubovskaya I; Kruchkova I; Bondarenko S; Vavilov V; Stancheva N; Babenko E; Sipol A; Pronkina N; Kozlov V; Afanasyev B
Br J Haematol; 2014 Feb; 164(4):546-54. PubMed ID: 24261566
[TBL] [Abstract][Full Text] [Related]
14. Relapse of aplastic anemia responsive to sirolimus combined with cyclosporine.
He G; Zhang X; Wu D; Sun A; Wang X
Pediatr Blood Cancer; 2011 Jul; 56(7):1133-5. PubMed ID: 21488160
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive therapy in adults with aplastic anaemia: single-institution experience from India.
Nair V; Sharma A; Das S; Sondhi V; Sharma S
Postgrad Med J; 2013 Sep; 89(1055):508-15. PubMed ID: 23686628
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin is highly effective in murine models of immune-mediated bone marrow failure.
Feng X; Lin Z; Sun W; Hollinger MK; Desierto MJ; Keyvanfar K; Malide D; Muranski P; Chen J; Young NS
Haematologica; 2017 Oct; 102(10):1691-1703. PubMed ID: 28729300
[TBL] [Abstract][Full Text] [Related]
17. Aplastic anemia: management of adult patients.
Maciejewski JP; Risitano AM
Hematology Am Soc Hematol Educ Program; 2005; ():110-7. PubMed ID: 16304367
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.
Jalaeikhoo H; Khajeh-Mehrizi A
PLoS One; 2015; 10(5):e0126925. PubMed ID: 25970182
[TBL] [Abstract][Full Text] [Related]
19. Immune-mediated cytopenias in human immunodeficiency virus: the first reported case of idiopathic aplastic anaemia successfully treated with immunosuppression.
Hapgood G; Hoy JF; Morrissey CO; Jane SM
Intern Med J; 2013 Apr; 43(4):452-5. PubMed ID: 23551309
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of CX3C chemokine receptor 1 mediates recruitment of T cells into bone marrow of patients with acquired aplastic anaemia.
Ren J; Hou XY; Ma SH; Zhang FK; Zhen JH; Sun L; Sun YX; Hao YL; Cheng YF; Hou M; Xu CG; Zhang MH; Peng J
J Intern Med; 2014 Nov; 276(5):512-24. PubMed ID: 24528288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
